Respiratory therapy

Eight US Manufacturers Selected to Make NASA COVID-19 Ventilator

Friday, May 29, 2020 - 8:14pm

WASHINGTON, May 29, 2020 /PRNewswire/ --After receiving more than 100 applications, NASA's Jet Propulsion Laboratory (JPL) in Southern California has selected eight U.S. manufacturers to make a new ventilator tailored for coronavirus (COVID-19) patients.

Key Points: 
  • WASHINGTON, May 29, 2020 /PRNewswire/ --After receiving more than 100 applications, NASA's Jet Propulsion Laboratory (JPL) in Southern California has selected eight U.S. manufacturers to make a new ventilator tailored for coronavirus (COVID-19) patients.
  • Called VITAL (Ventilator Intervention Technology Accessible Locally), the high-pressure ventilatorwas designed to use one-seventh the parts of a traditional ventilator, relying on parts already available in supply chains.
  • It offers a simpler, more affordable option for treating critical patients while freeing up traditional ventilators for those with the most severe COVID-19 symptoms.
  • The compressed-air design also has been submitted to the FDA for a ventilator Emergency Use Authorization and is currently under review.

Global Critical Care Devices Market: Projected to be Valued at $37.97 Billion in 2020 and $27.29 Billion in 2021

Friday, May 29, 2020 - 4:00pm

The global critical care devices market is projected to grow at a CAGR of 44.6% from 2019 to 2020.

Key Points: 
  • The global critical care devices market is projected to grow at a CAGR of 44.6% from 2019 to 2020.
  • The market for critical care devices is driven primarily by the increasing number of ICU beds owing to the continuously rising COVID-19 cases, increasing demand for ventilators for effective management of critical COVID-19 patients, and ease of regulatory requirements to facilitate the production of critical care devices.
  • Based on the product, the infusion pump segment accounted for the largest share of the critical care devices market in 2019.
  • Based on end-users, the hospital segment accounted for the largest share of the critical care devices market in 2019.

Non-invasive oXygen Therapies Delay or Prevent Intubation but Are Believed to Aerosolize Coronavirus by 80% of Global Physicians Treating COVID-19 in Hospitals

Friday, May 29, 2020 - 2:48pm

One possible reason is that the overwhelming majority of physicians believe non-invasive oxygen therapies put hospital staff and other patients at risk by aerosolizing the virus.

Key Points: 
  • One possible reason is that the overwhelming majority of physicians believe non-invasive oxygen therapies put hospital staff and other patients at risk by aerosolizing the virus.
  • Patients quickly developed breathing difficulties, treatment protocols were created on the fly, and rapid intubation was encouraged based on older guidelines.
  • Oxygen blood levels have typically driven decisions about breathing support and intubation, but with COVID-19 they might be misleading.
  • Sermo is the largest healthcare data collection company and social platform for physicians, reaching 1,3MM healthcare professionals across 150 countries.

Global Asthma Market and Competitive Landscape 2020 - ResearchAndMarkets.com

Friday, May 29, 2020 - 8:04am

The "Global Asthma Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Asthma Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive insights into the Asthma pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts the Asthma market size and drug sales.
  • This research covers the following: Asthma treatment options, Asthma late stage clinical trials pipeline, Asthma prevalence by countries, Asthma market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.

Global Respiratory Monitoring Devices Market 2020-2030: COVID-19 Implications and Growth - ResearchAndMarkets.com

Thursday, May 28, 2020 - 5:13pm

The "Global Respiratory Monitoring Devices Market 2020-2030: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Respiratory Monitoring Devices Market 2020-2030: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.
  • It places the market within the context of the wider respiratory monitoring devices market, and compares it with other markets.
  • Longer duration of time taken in the approval process of respiratory devices is restricting the growth of respiratory monitoring devices market.
  • It compares the respiratory monitoring devices market with other segments of the respiratory monitoring devices market by size and growth, historic and forecast.

Global Medical Oxygen Concentrators & Cylinders Market, 2020-2026 - Impact of COVID-19, Opportunity Analysis, Product Substitutes

Thursday, May 28, 2020 - 2:45pm

DUBLIN, May 28, 2020 /PRNewswire/ -- The "Medical Oxygen Concentrators & Oxygen Cylinders Market Size, Share & Trends Analysis Report by Product, by Technology, by End-user, by Region, and Segment Forecasts, 2020-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 28, 2020 /PRNewswire/ -- The "Medical Oxygen Concentrators & Oxygen Cylinders Market Size, Share & Trends Analysis Report by Product, by Technology, by End-user, by Region, and Segment Forecasts, 2020-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global medical oxygen concentrators & oxygen cylinders market size is expected to reach USD 3.7 billion by 2026, expanding at a CAGR of 4.2% over the forecast period.
  • Technological improvements in oxygen concentrators, such as lesser weight, greater efficiency, high oxygen output, are anticipated to raise demand for portable concentrators, thereby aiding growth of the market.
  • Increasing prevalence of COPD, growing geriatric population, and technology advancements are driving the usage of these medical devices amongst people in the U.S.
    2.4 Global Medical Oxygen Concentrators & Oxygen Cylinders Market Snapshot, Revenue (USD Million)
    2.5 Global Medical Oxygen Concentrators & Oxygen Cylinders Market Snapshot, Volume (Units)
    Chapter 3 Global Medical Oxygen Concentrators & Oxygen Cylinders Market Variables, Trends, & Scope

CalciMedica Announces Positive Topline Data from Interim Analysis of Trial Evaluating Auxora™ in Patients with Severe COVID-19 Pneumonia

Thursday, May 28, 2020 - 1:00pm

The interim analysis showed Auxora plus standard of care reduced ventilator use and improved time to recovery in treated patients compared to standard of care alone.

Key Points: 
  • The interim analysis showed Auxora plus standard of care reduced ventilator use and improved time to recovery in treated patients compared to standard of care alone.
  • The open-label study consists of 26 patients enrolled while on low-flow oxygen and randomized 2:1 to receive Auxora versus standard of care.
  • The interim analysis showed that treated patients had a greater than 50% reduction in the proportion of patients put on ventilators in the course of therapy as compared to standard of care patients.
  • Additionally, the length of hospital stay for Auxora treated patients was more than 50% shorter than for standard of care patients.

Patent Issuance Allowed for Single-Use or Short-Term Nitric Oxide Delivery Device

Thursday, May 28, 2020 - 1:00pm

(OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trademark Office (USPTO) has allowed the issuance of a patent for a single-use or short-term use nitric oxide inhaler.

Key Points: 
  • (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, today announced that the United States Patent and Trademark Office (USPTO) has allowed the issuance of a patent for a single-use or short-term use nitric oxide inhaler.
  • Typically, nitric oxide delivery devices are large, electronically complex devices that are used primarily in neonatal intensive care units.
  • Jeff Robins, Chief Executive Officer of Nu-Med Plus, stated, This patent allowance is a significant achievement for our Company and can help open new patient markets.
  • The Utah-based medical device company is currently in the process of filing for FDA approval for their NMP-200 hospital nitric oxide delivery unit.

African and Global Philanthropists Team-up to Manufacture COVID-19 Medical Equipment in Africa

Wednesday, May 27, 2020 - 8:30am

LONDON, May 27, 2020 /PRNewswire/ -- African and global philanthropists have teamed up to help African nations secure urgently needed ventilators, breathing support devices and other medical equipment, in the battle against the COVID-19 pandemic.

Key Points: 
  • LONDON, May 27, 2020 /PRNewswire/ -- African and global philanthropists have teamed up to help African nations secure urgently needed ventilators, breathing support devices and other medical equipment, in the battle against the COVID-19 pandemic.
  • Working with fellow philanthropists Sir Richard Branson and Jeff Skoll, the group have identified two solutions which will be manufactured in South Africa.
  • "We have found a major South African company called Invicta Holdings that can mass produce these bridge ventilators and oxygen helmets.
  • Masiyiwa has also pulled together a team to build an online platform to manage global procurement of medical equipment, including PPE.

African and Global Philanthropists Team-up to Manufacture COVID-19 Medical Equipment in Africa

Wednesday, May 27, 2020 - 8:30am

LONDON, May 27, 2020 /PRNewswire/ -- African and global philanthropists have teamed up to help African nations secure urgently needed ventilators, breathing support devices and other medical equipment, in the battle against the COVID-19 pandemic.

Key Points: 
  • LONDON, May 27, 2020 /PRNewswire/ -- African and global philanthropists have teamed up to help African nations secure urgently needed ventilators, breathing support devices and other medical equipment, in the battle against the COVID-19 pandemic.
  • Working with fellow philanthropists Sir Richard Branson and Jeff Skoll, the group have identified two solutions which will be manufactured in South Africa.
  • "We have found a major South African company called Invicta Holdings that can mass produce these bridge ventilators and oxygen helmets.
  • Masiyiwa has also pulled together a team to build an online platform to manage global procurement of medical equipment, including PPE.